Response to: Comment on ‘Circulating cell-free miRNAs as biomarker for triple-negative breast cancer’

被引：0
|
作者：
Vivian Y Shin
Ava Kwong
机构：
[1] The University of Hong Kong,Department of Surgery
[2] The Hong Kong Hereditary Breast Cancer Family Registry,Department of Surgery
[3] Hong Kong Sanatorium & Hospital,undefined
来源：
British Journal of Cancer | 2016年 / 114卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：e6 / e6
相关论文
共 50 条
  • [31] Circulating tumour mutation detection in triple-negative breast cancer as an adjunct to tissue response assessment
    Zaikova, Elena
    Cheng, Brian Y. C.
    Cerda, Viviana
    Kong, Esther
    Lai, Daniel
    Lum, Amy
    Bates, Cherie
    den Brok, Wendie
    Kono, Takako
    Bourque, Sylvie
    Chan, Angela
    Feng, Xioalan
    Fenton, David
    Gurjal, Anagha
    Levasseur, Nathalie
    Lohrisch, Caroline
    Roberts, Sarah
    Shenkier, Tamara
    Simmons, Christine
    Taylor, Sara
    Villa, Diego
    Miller, Ruth
    Aguirre-Hernandez, Rosalia
    Aparicio, Samuel
    Gelmon, Karen
    NPJ BREAST CANCER, 2024, 10 (01)
  • [32] Circulating tumour mutation detection in triple-negative breast cancer as an adjunct to tissue response assessment
    Elena Zaikova
    Brian Y. C. Cheng
    Viviana Cerda
    Esther Kong
    Daniel Lai
    Amy Lum
    Cherie Bates
    Wendie den Brok
    Takako Kono
    Sylvie Bourque
    Angela Chan
    Xioalan Feng
    David Fenton
    Anagha Gurjal
    Nathalie Levasseur
    Caroline Lohrisch
    Sarah Roberts
    Tamara Shenkier
    Christine Simmons
    Sara Taylor
    Diego Villa
    Ruth Miller
    Rosalia Aguirre-Hernandez
    Samuel Aparicio
    Karen Gelmon
    npj Breast Cancer, 10
  • [33] CD73: a new biomarker in triple-negative breast cancer
    Lafont, Virginie
    Michaud, Henri-Alexandre
    Bonnefoy, Nathalie
    TRANSLATIONAL CANCER RESEARCH, 2018, 7 : S594 - S596
  • [34] Androgen receptor as a mediator and biomarker of radioresistance in triple-negative breast cancer
    Speers, Corey
    Zhao, Shuang G.
    Chandler, Ben
    Liu, Meilan
    Wilder-Romans, Kari
    Olsen, Eric
    Nyati, Shyam
    Ritter, Cassandra
    Alluri, Prasanna G.
    Kothari, Vishal
    Hayes, Daniel F.
    Lawrence, Theodore S.
    Spratt, Daniel E.
    Wahl, Daniel R.
    Pierce, Lori J.
    Feng, Felix Y.
    NPJ BREAST CANCER, 2017, 3 : 1 - 10
  • [35] Androgen receptor as a mediator and biomarker of radioresistance in triple-negative breast cancer
    Corey Speers
    Shuang G. Zhao
    Ben Chandler
    Meilan Liu
    Kari Wilder-Romans
    Eric Olsen
    Shyam Nyati
    Cassandra Ritter
    Prasanna G. Alluri
    Vishal Kothari
    Daniel F. Hayes
    Theodore S. Lawrence
    Daniel E. Spratt
    Daniel R. Wahl
    Lori J. Pierce
    Felix Y. Feng
    npj Breast Cancer, 3
  • [36] Peroxiporins in Triple-Negative Breast Cancer: Biomarker Potential and Therapeutic Perspectives
    Bijelic, Anita
    Silovski, Tajana
    Mlinaric, Monika
    Gasparovic, Ana Cipak
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (12)
  • [37] TTK is a favorable prognostic biomarker for triple-negative breast cancer survival
    Xu, Qianqian
    Xu, Yali
    Pan, Bo
    Wu, Liangcai
    Ren, Xinyu
    Zhou, Yidong
    Mao, Feng
    Lin, Yan
    Guan, Jinghong
    Shen, Songjie
    Zhang, Xiaohui
    Wang, Changjun
    Zhong, Ying
    Zhou, Liangrui
    Liang, Zhiyong
    Zhao, Haitao
    Sun, Qiang
    ONCOTARGET, 2016, 7 (49) : 81815 - 81829
  • [38] Circulating Tumor Cell Analysis in Metastatic Triple-Negative Breast Cancers
    Magbanua, Mark Jesus M.
    Carey, Lisa A.
    DeLuca, Amy
    Hwang, Jimmy
    Scott, Janet H.
    Rimawi, Mothaffar F.
    Mayer, Erica L.
    Marcom, P. Kelly
    Liu, Minetta C.
    Esteva, Francisco J.
    Park, John W.
    Rugo, Hope S.
    CLINICAL CANCER RESEARCH, 2015, 21 (05) : 1098 - 1105
  • [39] Cell stress and apoptosis associated biomarker expression correlates with triple-negative breast cancer prognosis
    Nagy, A.
    Krenacs, T.
    VIRCHOWS ARCHIV, 2019, 475 : S370 - S370
  • [40] Comment on "Histomorphological Factors Predicting the Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer" Reply
    Ryu, Han Suk
    JOURNAL OF BREAST CANCER, 2017, 20 (01) : 114 - 115
12345